CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Kewen Qian(Shanghai Medical College of Fudan University), Shi Hu(Second Military Medical University)
Cited by 28
Related Papers
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
|Nature Communications|2019|484
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
|Nature Communications|2020|432
Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig
|bioRxiv (Cold Spring Harbor Laboratory)|2020|94
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody
|Molecular Immunology|2017|23
Development and Optimization of Therapeutic Analogues of Anti-TNFα Antibody Infliximab
|Molecular Biology|2018|0